Brian Walking! After a month of stem cell treatment in China this summer, Brian is on the move! Follow Brian's progress at iheartbrian.comFrom:medicman65Views:0 0ratingsTime:01:07More inPeople Blogs Read this article: Brian Walking! - Video … Continue reading →

Rejuvenare - I don't have time to wait for approval in the US Patient Jerry relates why he chose Rejuvenare stem cell therapy to treat Parkinson's outside the US. Although he'd earlier been successful keeping the disease's progression slowed, they were no longer effective for him and he was told it would be about 10 years before this procedure was approved in the USFrom:rejuvenareViews:0 0ratingsTime:01:24More inEducation See the rest here: Rejuvenare - I don't have time to wait for approval in the US - Video … Continue reading →

Rejuvenare stem cell treatment for stroke.mov Rejuvenare CEO Carlo Velarde relates how his mother, completely incapacitated by a crippling stroke, has regained her quality of life, her mobility, her thought process after undergoing stem cell therapy for stroke.From:rejuvenareViews:0 0ratingsTime:00:47More inEducation Visit link: Rejuvenare stem cell treatment for stroke.mov - Video … Continue reading →

CARLSBAD, CA--(Marketwire - Nov 13, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company, today announced the commercial launch of its newest stem cell based skin care product by wholly-owned subsidiary Lifeline Skin Care, Inc. The new Lifeline Eye Firming Complex is now available to shareholders, followers and supporters of ISCO and Lifeline Skin Care. The product will be available online (www.lifelineskincare.com), in selected spas and medical clinics on November 15, 2012. Lifeline Eye Firming Complex complements the current anti-aging product line introduced in November 2010 and available in selected luxury spas, medical offices and online. The new, extended Lifeline product line will be promoted by recently engaged celebrities including Emme, the supermodel and author who was twice-named one of People magazine's 50 Most Beautiful People, and Glamour magazine's Woman of the Year; and Jennifer Galardi, a celebrity trainer, nationally recognized fitness and yoga guru, and the face for fitness brands Adidas, Under Armour, New Balance and Nike. According to supermodel and beauty expert Emme, "Women are concerned about their appearance, and they're especially concerned about the lines and wrinkles around their eyes. That's why they'll like Lifeline's new … Continue reading →

UCI discovery accelerates efforts at Sue & Bill Gross Stem Cell Research Center UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimers. Dr. Edwin Monuki of UCIs Sue & Bill Gross Stem Cell Research Center, developmental & cell biology graduate student Momoko Watanabe and colleagues developed these cells called choroid plexus epithelial cells from existing mouse and human embryonic stem cell lines. CPECs are critical for proper functioning of the choroid plexus, the tissue in the brain that produces cerebrospinal fluid. Among their various roles, CPECs make CSF and remove metabolic waste and foreign substances from the fluid and brain. In neurodegenerative diseases, the choroid plexus and CPECs age prematurely, resulting in reduced CSF formation and decreased ability to flush out such debris as the plaque-forming proteins that are a hallmark of Alzheimers. Transplant studies have provided proof of concept for CPEC-based therapies. However, such therapies have been hindered by the inability to expand or generate CPECs in culture. Our method is promising, because for the first time we can use stem cells to create large amounts of these epithelial cells, which could be utilized in different ways … Continue reading →

JERUSALEM--(BUSINESS WIRE)-- Gamida Cell Ltd., a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine, announced today that the first patient, enrolled in its pilot study of NiCord as an investigational treatment for sickle cell disease (SCD), has been transplanted at Duke University in North Carolina. Gamida Cell CEO Dr. Yael Margolin said, The NiCord study is a first step in broadening Gamida Cells pipeline of cell therapies to treat patients who suffer from severe non-malignant diseases with a very large unmet clinical need. SCD is a group of inherited red blood cell disorders where red blood cells become hard and sticky and look like a C-shaped farm tool called a sickle. According to statistics, SCD affects 90,000 to 100,000 in the US alone, mainly African-Americans and Hispanic-Americans. Symptoms range in type and severity. SCD can be fatal and to date, the only cure for SCD is stem cell transplantation from a family related matched donor. Dr. Margolin continued, Sickle cell disease can be cured with a successful bone marrow transplantation, especially from a family related fully matched donor. Most patients do not pursue this option, since they do not have … Continue reading →

ScienceDaily (Nov. 13, 2012) A University of Cincinnati (UC) Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated -- and then grown -- in a preclinical model, offering a new avenue for investigating immunotherapy treatment options that specifically target stem cells. John C. Morris, MD, and his colleagues report their findings in the Nov. 13, 2012, issue of PLoS One, a peer-reviewed online publication. Stem cells are unique cells that can divide and differentiate into specialized cells types -- for example cardiac muscle or liver tissue. These cells also have the ability to self-renew and produce more stem cells. "Increasing evidence supports the idea that cancerous tumors have a population of stem cells, also called cancer-initiating cells, that continually regenerate and fuel cancer growth," explains Morris, senior author of the study and professor at the UC College of Medicine. "These cancer stem cells may also have the highest potential to spread to other organs." Current models used to study cancer stem cells provide limited information on the interaction between cancer stem cells with the immune system, making the study of new therapies that utilize the body's immune system to fight off cancer virtually impossible. … Continue reading →